Nusinersen Treatment in Adults With Spinal Muscular Atrophy

OBJECTIVE: To determine changes in motor and respiratory function after treatment with nusinersen in adults with spinal muscular atrophy (SMA) during the first two years of commercial availability in the USA. METHODS: Data were collected prospectively on adult (age >17 years at treatment initiati...

Descripción completa

Detalles Bibliográficos
Autores principales: Duong, Tina, Wolford, Connie, McDermott, Michael P., Macpherson, Chelsea E., Pasternak, Amy, Glanzman, Allan M., Martens, William B., Kichula, Elizabeth, Darras, Basil T., De Vivo, Darryl C., Zolkipli-Cunningham, Zarazuela, Finkel, Richard S., Zeineh, Michael, Wintermark, Max, Sampson, Jacinda, Hagerman, Katharine A., Young, Sally Dunaway, Day, John W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382360/
https://www.ncbi.nlm.nih.gov/pubmed/34476123
http://dx.doi.org/10.1212/CPJ.0000000000001033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382360/
https://www.ncbi.nlm.nih.gov/pubmed/34476123
http://dx.doi.org/10.1212/CPJ.0000000000001033

Ejemplares similares